Taiwan Tessie Che, chairperson & GM of Amaran Biotech shares the story of how she came to lead the company and set its course to become a leading specialty biopharma CMO that leverages high-quality products and best manufacturing practices above all else. As a veteran in the life sciences and pharma…
Puerto Rico CRB is a global consulting, design and construction services firm specialized in the life sciences industry. Tom Forester, general manager of CRB Caribe, based in Puerto Rico, shares the developments of the company in the past few years, what makes CRB the partner of choice for life sciences companies and…
Taiwan Ying-Yao Cheng, president of National Sun Yat-sen University, highlights the institution’s specialized expertise in marine sciences and goes on to elaborate on the important role of NSYSU in developing talent, translational research, and innovation both domestically and internationally. Cheng also describes the university’s capabilities in cross-disciplinary research projects, particularly in…
Thailand Thailand is known around the world for its lush landscapes, ancient architecture and breathtaking beaches. The nation receives more than 35 million visitors each year. Thailand ranked 4th globally for adventure value and 7th for cultural heritage in US News’ 2017 Best Countries Report, and Bangkok consistently ranks among the…
Puerto Rico Giuseppe Allocca, Pfizer’s site leader for its Vega Baja & Barceloneta operations in Puerto Rico, highlights the importance of Pfizer’s manufacturing operations on the island, with 14 of the company’s key products manufactured there. Puerto Rico boasts one of the most talented workforces in pharmaceutical manufacturing in the world,…
China China’s pharma market is growing at an unprecedented pace and has become a key element of virtually all pharma multinationals’ international strategies. However, with a spate of regulatory reforms being rolled out, it can be challenging for large organizations with headquarters located in slower-paced mature markets to adapt to China’s…
USA Although Boston and California may be more internationally renowned as biotech hubs, New York is fast catching up. Thanks in large part to its strong scientific and business infrastructure and easy access to capital, growing numbers of early-stage biotechs are choosing to base their operations in New York and list…
France With Minister of the Economy and Finance, Bruno Le Maire, emphasizing the importance of “winning the battle on data” and eccentric mathematician Cédric Villani, well in the process of drawing up a national strategy on artificial intelligence (AI) in his capacity as Chargé de Mission, there is little doubting the…
France France – one of the most influential countries in the development of gene therapy– still stands as a global powerhouse in the field, with top-class institutions, a dense network of expertise and increasing political support. However, financing and manufacturing French gene therapies is proving an issue, meaning that France is…
France With a feel-good factor sweeping French innovative pharma, the country’s iconic mid-cap biopharma standard-bearers are once more on the rise. These medium-sized national champions form part of G5 Santé, a club of companies altogether contributing some EUR 4.5 billion (USD 5 billion) worth of turnover to the home market and…
Korea Industry players – from Big Pharma giants to small local startups – are bringing new, innovative solutions to market in Korea in order to try and solve the country’s diabetes epidemic. The growing prevalence of Type 2 Diabetes is becoming a global issue. According to Dr Nam Han Cho,…
Korea The nation of South Korea has overtaken many of its regional counterparts to boast a highly impressive biosimilars pipeline. Here, key stakeholders in Korean biologics and biosimilars explain how. Once we chose to specialise in biosimilars, there was no room to survive if we failed with the few projects…
See our Cookie Privacy Policy Here
